Combined approach of high-power and very high-power, short-duration ablation in superior vena cava isolation.

Autor: Makita T; Department of Cardiology, Tokyo Heart Rhythm Clinic, Tokyo, Japan., Kuwahara T; Department of Cardiology, Tokyo Heart Rhythm Clinic, Tokyo, Japan., Takahashi K; Department of Cardiology, Tokyo Heart Rhythm Clinic, Tokyo, Japan., Oshio T; Department of Clinical Engineering and Nursing, Tokyo Heart Rhythm Clinic, Tokyo, Japan., Kadono K; Department of Clinical Engineering and Nursing, Tokyo Heart Rhythm Clinic, Tokyo, Japan., Oyagi Y; Department of Clinical Engineering and Nursing, Tokyo Heart Rhythm Clinic, Tokyo, Japan., Ito Y; Department of Clinical Engineering and Nursing, Tokyo Heart Rhythm Clinic, Tokyo, Japan., Takahashi R; Department of Clinical Engineering and Nursing, Tokyo Heart Rhythm Clinic, Tokyo, Japan.
Jazyk: angličtina
Zdroj: Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2024 Nov; Vol. 35 (11), pp. 2144-2152. Date of Electronic Publication: 2024 Sep 09.
DOI: 10.1111/jce.16424
Abstrakt: Introduction: The effectiveness and safety of 50 W, high-power, short-duration (HPSD) ablation in superior vena cava isolation (SVCI) for patients with atrial fibrillation (AF) have been reported. However, the acute outcomes of SVCI combined with 90 W/4 s, very high-power, short-duration (vHPSD) ablation remain unknown. In this study, we aimed to investigate a novel approach that combines 50 W-HPSD and 90 W/4 s-vHPSD ablation in SVCI and to elucidate the characteristics, outcomes, and safety of this approach by comparing SVCI with conventional ablation index (AI)-guided middle-power, middle-duration (MPMD) ablation.
Methods: Overall, 126 patients who underwent AF ablation with SVCI using the QDOT MICRO TM catheter were retrospectively reviewed; one group underwent SVCI with a combined approach of HPSD and vHPSD ablation (50 W/90 W group, n = 73) and another group underwent AI-guided MPMD ablation (30-40 W group, n = 53). This study compared the procedural details, radiofrequency (RF) ablation profiles, and complications. The RF settings used in the 50 W/90 W group were 50 W/7 s for the lateral segment close to the phrenic nerve and 90 W/4 s for the nonlateral segment.
Results: The 50 W/90 W group required a significantly shorter procedural time (3.2 vs. 5.9 min, p < .001), shorter RF duration (42.0 vs. 162.0 s, p < .001), and lower RF energy (2834 vs. 5480 J, p < .001) than the 30-40 W group. Procedural success, first-pass SVCI, number of RF applications, and SVC reconnection after isoproterenol loading were comparable between the groups. The maximum tip-electrode temperature of the multi-thermocouple system was significantly higher in the 50 W/90 W group than in the 30-40 W group (50.0°C vs. 47.0°C, p < .001). No complications, such as phrenic nerve injury or bleeding requiring transfusion, were observed in either group.
Conclusions: The combined approach of 50 W/7 s-HPSD and 90 W/4 s-vHPSD ablation resulted in successful and safe SVCI with shorter procedural time, shorter RF duration, and lower RF energy.
(© 2024 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: